{
  "id": 16017597,
  "title": "SMEH Subsidiary Wins Ethamolin Exclusive Saudi Agency",
  "url": "https://urgent.news/2026/10/22/smeh-subsidiary-wins-ethamolin-exclusive-saudi-agency",
  "topic": "culture",
  "section": "Culture",
  "published": "2026-10-22T08:24:44.000Z",
  "source": {
    "name": "The Saudi Standard",
    "slug": "the-saudi-standard",
    "url": "https://saudistandard.com/2026/10/22/smeh-subsidiary-wins-ethamolin-exclusive-saudi-agency/"
  },
  "original_language": "en",
  "account": "Saudi company Scientific & Medical Equipment House (SMEH) has signed an exclusive 2030 distribution agreement with Qarqas Trading Company Pharmaceutical Warehouse. This subsidiary will have sole rights to sell Ethamolin®, an FDA-approved drug for treating bleeding esophageal varices, throughout Saudi Arabia. The deal was officially registered by the Ministry of Commerce. Ethamolin® is currently supplied to NUPCO, the government's central healthcare procurement body. Once the Saudi Food and Drug Authority (SFDA) grants the final license, Qarqas will hold full regulatory standing to market the drug independently, potentially expanding its availability beyond the government procurement channel.",
  "summary": "Riyadh, Saudi Arabia — Scientific & Medical Equipment House Company (SMEH) announced that its wholly owned subsidiary, Qarqas Trading Company Pharmaceutical Warehouse, has secured the exclusive distribution agency for Ethamolin® in Saudi Arabia. The agreement runs until 2030 and covers a U.S. Food and Drug Administration-approved drug used to treat bleeding esophageal varices. The counterparty…",
  "key_points": [
    "SMEH subsidiary secures exclusive Saudi distribution rights for Ethamolin.",
    "2030 agreement signed with Qarqas Trading Company Pharmaceutical Warehouse.",
    "Ethamolin to be marketed independently after SFDA license approval."
  ],
  "editors_take": "Securing exclusive distribution rights allows the subsidiary to bypass government-only procurement channels and expand the drug's market presence across the Saudi healthcare landscape once final regulatory approval is granted.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}